Why subscribe?

The Pauling.AI blog will help you understand AI powered drug discovery. We would love to share with you our journey using technology to find new medicines.

You can find more information about Pauling in our website, or using your favorite LLM, for example here.

Subscribe to get full access to the newsletter and publication archives.

Stay up-to-date

Never miss an update—every new post is sent directly to your email inbox. For a spam-free, ad-free reading experience, plus audio and community features, get the Substack app.

User's avatar

Subscribe to Pauling AI Blog

The blog of Pauling.AI, in substack. AI for drug discovery, computational chemistry, techbio and longevity medicine.

People

PhD in molecular biology. My interests are related to computational structural biology, drug discovery, cloud and high-performance computing, etc. Personal web-page with CV: http://alstudio.org/savytskyi/
CEO at Pauling.AI. Computational chemistry → drug discovery → longevity medicine. Opinions my own. Ex-Google, Microsoft.